Document is current
Any future updates will be listed below
-
Authors
Chaitra, R.
Gandhi, Rohit
Jayanna, N.
Satyanath, Sachin
Pavadai, Parasuraman
Murahari, Manikanta https://orcid.org/0000-0002-5404-4426
- License Information
-
More Information
Article History
Received: 28 January 2022
Accepted: 7 April 2022
First Online: 28 April 2022
Declarations
:
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: Not applicable. Study involved the design of potential hit compounds for MmpL3 target protein using different computational approaches of Schrodinger Drug Design Suite.
: Not applicable. As the study involved only in silico approaches using computational tools.
: All authors agree with the content and obtained consent from the responsible authorities at the institute/organization where the work has been carried out.
